Editing out five Serpina1 paralogs to create a mouse model of genetic emphysema.
Editing out five Serpina1 paralogs to create a mouse model of genetic emphysema.
复制标题
DOI:
10.1073/pnas.1713689115
复制
发表时间:
2018-03-13
影响因子:
11.1
通讯作者:
Mueller C
中科院分区:
文献类型:
--
作者:
Borel F;Sun H;Zieger M;Cox A;Cardozo B;Li W;Oliveira G;Davis A;Gruntman A;Flotte TR;Brodsky MH;Hoffman AM;Elmallah MK;Mueller C
Chronic obstructive pulmonary disease affects 10% of the worldwide population, and the leading genetic cause is a genetic disease, α-1 antitrypsin (AAT) deficiency. Humans have only one gene that codes for the AAT protein, but mice have up to six, which made it impossible for decades to create a mouse model of the disease. Here we succeeded in creating this mouse model using CRISPR technology to target all of the mouse genes at once. Importantly, this mouse model spontaneously develops lung disease and recapitulates many aspects of the human disease. We anticipate that this model will be highly relevant not only to the preclinical development of therapeutics for AAT deficiency, but also to emphysema and smoking research. Chronic obstructive pulmonary disease affects 10% of the worldwide population, and the leading genetic cause is α-1 antitrypsin (AAT) deficiency. Due to the complexity of the murine locus, which includes up to six Serpina1 paralogs, no genetic animal model of the disease has been successfully generated until now. Here we create a quintuple Serpina1a–e knockout using CRISPR/Cas9-mediated genome editing. The phenotype recapitulates the human disease phenotype, i.e., absence of hepatic and circulating AAT translates functionally to a reduced capacity to inhibit neutrophil elastase. With age, Serpina1 null mice develop emphysema spontaneously, which can be induced in younger mice by a lipopolysaccharide challenge. This mouse models not only AAT deficiency but also emphysema and is a relevant genetic model and not one based on developmental impairment of alveolarization or elastase administration. We anticipate that this unique model will be highly relevant not only to the preclinical development of therapeutics for AAT deficiency, but also to emphysema and smoking research.
登录
查看更多内容
DOI:
10.1016/j.ymthe.2017.09.020
发表时间:
2017-11-01
期刊:
Molecular therapy : the journal of the American Society of Gene Therapy
影响因子:
--
作者:
Borel F;Tang Q;Gernoux G;Greer C;Wang Z;Barzel A;Kay MA;Shultz LD;Greiner DL;Flotte TR;Brehm MA;Mueller C
通讯作者:
Mueller C
DOI:
10.1093/bioinformatics/btu638
发表时间:
2015-01-15
期刊:
Bioinformatics (Oxford, England)
影响因子:
--
作者:
Anders S;Pyl PT;Huber W
通讯作者:
Huber W
DOI:
10.1016/j.ymthe.2017.03.029
发表时间:
2017-06-07
期刊:
Molecular therapy : the journal of the American Society of Gene Therapy
影响因子:
--
作者:
Mueller C;Gernoux G;Gruntman AM;Borel F;Reeves EP;Calcedo R;Rouhani FN;Yachnis A;Humphries M;Campbell-Thompson M;Messina L;Chulay JD;Trapnell B;Wilson JM;McElvaney NG;Flotte TR
通讯作者:
Flotte TR
影响因子:
15.9
作者:
NAKAMURA, H;YOSHIMURA, K;CRYSTAL, RG
通讯作者:
CRYSTAL, RG
影响因子:
15.9
作者:
Mueller, Christian;Chulay, Jeffrey D.;Flotte, Terence R.
通讯作者:
Flotte, Terence R.